Priyanka Jha

Priyanka Jha

Auto-generated profile, based on publicly available information

Priyanka Jha

Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in Radiology
Verified
Journal Article
Closed access
ESElizabeth A. Sadowski
Elizabeth A. Sadowski
ITIsabelle Thomassin-Nagarra
Isabelle Thomassin-Nagarra
ARAnd Andrea G. Rockall
And Andrea G. Rockall
KMKatherine E. Maturen
Katherine E. Maturen
RFRosemarie Forstner
Rosemarie Forstner
CRCaroline Reinhold
Caroline Reinhold
The Ovarian-Adnexal Reporting and Data System MRI risk score is a stratification system for assigning malignancy probability to adnexal lesions and can improve communication between radiologists an... MRI plays an important role as a secondary test or problem-solving modality in the evaluation of adnexal lesions depicted at US. MRI has increased specificity compared with US, decreasing the numbe...

10 February 2020 in European Radiology
Verified
Journal Article
Closed access
PDF file
PJPriyanka Jha
Priyanka Jha
LPLiina Pōder
Liina Pōder
CBCharis Bourgioti
Charis Bourgioti
NBNishat Bharwani
Nishat Bharwani
SLSara Lewis
Sara Lewis
GMGabriele Masselli
Gabriele Masselli

1 September 2023 in Radiology
Verified
Journal Article
Closed access
LSLori M. Strachowski
Lori M. Strachowski
PJPriyanka Jha
Priyanka Jha
CPCatherine H. Phillips
Catherine H. Phillips
MPMisty M. Blanchette Porter
Misty M. Blanchette Porter
WFWouter Froyman
Wouter Froyman
RARochelle F. Andreotti
Rochelle F. Andreotti
First published in 2019, the Ovarian-Adnexal Reporting and Data System (O-RADS) US provides a standardized lexicon for ovarian and adnexal lesions, enables stratification of these lesions with use of a numeric score based on morphologic features to indicate the risk of malignancy, and offers management guidance. This risk stratification system has subsequently been validated in retrospective studies and has yielded good interreader concordance, even with users of different levels of expertise. As use of the system increased, it was recognized that an update was needed to address certain clinical challenges, clarify recommendations, and incorporate emerging data from validation studies. Additional morphologic features that favor benignity, such as the bilocular feature for cysts without solid components and shadowing for solid lesions with smooth contours, were added to O-RADS US for optimal risk-appropriate scoring. As O-RADS US 4 has been shown to be an appropriate cutoff for malignancy, it is now recommended that lower-risk O-RADS US 3 lesions be followed with US if not excised. For solid lesions and cystic lesions with solid components, further characterization with MRI is now emphasized as a supplemental evaluation method, as MRI may provide higher specificity. This statement summarizes the updates to the governing concepts, lexicon terminology and assessment categories, and management recommendations found in the 2022 version of O-RADS US.

1 April 2024 in Radiology
Verified
Journal Article
Closed access
SYScott W. Young
Scott W. Young
PJPriyanka Jha
Priyanka Jha
LCLuciana Chamié
Luciana Chamié
SRShuchi Rodgers
Shuchi Rodgers
RKRosanne M. Kho
Rosanne M. Kho
WVWendaline VanBuren
Wendaline VanBuren
The Society of Radiologists in Ultrasound expert consensus provides recommendations for augmenting routine pelvic US examinations through additional maneuvers and imaging to improve diagnosis of deep endometriosis.

14 November 2019 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
PJPriyanka Jha
Priyanka Jha
MSMichelle Sakala
Michelle Sakala
LCLuciana Pardini Chamie
Luciana Pardini Chamie
MFMyra Feldman
Myra Feldman
NHNicole Hindman
Nicole Hindman
MTMyles T. Taffel
Myles T. Taffel

9 June 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
PJPriyanka Jha
Priyanka Jha
AGAkshya Gupta
Akshya Gupta
TBTimothy M. Baran
Timothy M. Baran
KMKatherine E. Maturen
Katherine E. Maturen
KPKrupa Patel-Lippmann
Krupa Patel-Lippmann
ESElizabeth A. Sadowski
Elizabeth A. Sadowski
When an adnexal lesion is discovered on pelvic ultrasonography, the goal of imaging is to assess if the lesion is benign or potentially malignant. Most adnexal lesions found on ultrasonography imaging are benign and can be classified as simple cysts, hemorrhagic cysts, endometriomas, and dermoids. The risk of malignancy in these lesions is extremely low.1-9 Lesions not meeting the criteria for 1 of these 4 classic benign lesions carry an increased risk of cancer.6,7,10-16 Multiple ultrasonography-based systems have been developed that use imaging features, such as solid tissue and vascularity, to risk stratify these lesions.1,3,5,13,17,18 Most recently, the Ovarian-Adnexal Reporting and Data Systems (O-RADS) Committee was formed under the American College of Radiology (ACR), and this international multidisciplinary group of experts developed the O-RADS ultrasound (US) Risk Stratification and Management System. This system is based on the published lexicon of the O-RADS US working group and from data collected in the International Ovarian Tumour Analysis (IOTA) study phase 1 to phase 3 prospective studies and other studies differentiating benign from potentially malignant lesions.1,2 The estimates for malignant neoplasm in the O-RADS US Risk Score table are based on the calculated frequency of malignant neoplasm from women undergoing surgery for known adnexal lesions in the IOTA study (Figure 1). The ACR O-RADS US committee acknowledges the limitations of applying a risk score stratification system founded on a database that includes only surgically resected lesions, which may overestimate the risk of malignant neoplasm in other populations.2